Dermatology groups in New York, Florida, California, and Illinois are losing revenue through Mohs modifier misuse, biopsy bundling errors, and payer-specific preauthorization denials. Generalist vendors overlook LCD compliance precision that directly impacts payment approval rates.
MBC maps every dermatology claim to medical necessity thresholds before submission and tracks provider-level net collection ratio so leadership sees exact performance variance by physician and payer.
When Moh's revenue swings month-to-month, documentation precision and payer intelligence are the underlying issues.
Call 888-357-3226 or Contact Us: https://bit.ly/4tLlfro
#DermatologyBillingUSA #MohsSurgery #NewYorkPhysicians #FloridaDermatology #CaliforniaMedicalGroups #RevenueLeakage #HealthcareEBITDA